Skip to main content

Table 2 Clinicopathological features between Ezrin (+) and Ezrin (-) hepatitis-B HCC patients

From: Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma

 

E (+) (n = 27) (%)

E (-) (n = 77) (%)

P

Age (years)

51.1 ± 13.3

52.6 ± 13.4

0.631

Gender (M:F)

24:3

62:15

0.323

Tumor size (cm)

5.0 ± 4.3

7.0 ± 4.7

0.049

AFP(ng/ml)

1288.1 ± 2898.0

2215.3 ± 3701.7

0.201

Cirrhosis (+)

23 (85.2)

44 (58.7)

0.013

Grading (Edmonson and Stainer)

  

0.044

Low-grade (I+ II)

6 (22.2)

34 (44.2)

 

High-grade (III+ IV)

21 (77.8)

43 (55.8)

 

Capsule formation (+)

16 (58.9)

50 (64.9)

0.642

Vascular invasion (+)

12 (44.4)

13 (16.9)

0.004

Satellite lesions (+)

11 (40.7)

16 (21.3)

0.050

Recurrence (+)

17 (63.0)

51 (66.2)

0.759

  1. M: male; F: female; AFP: α-fetoprotein